Uloric Related Clinical Trials
Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects. [Completed]
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study [Terminated]
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout [Recruiting]
Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease [Completed]
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment [Completed]
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment [Recruiting]
Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia [Completed]
Febuxostat Versus Allopurinol Control Trial in Subjects With Gout [Completed]
Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010 [Completed]
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout [Completed]
Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout [Completed]
Phase 1, Febuxostat XR Bioavailability Study [Recruiting]
Effect of Febuxostat on Blood Pressure [Completed]
Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina [Terminated]
The Effect of Uric Acid Lowering in Type 1 Diabetes [Recruiting]
Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones [Completed]
RDEA3170 and Febuxostat Drug Interaction Study [Completed]
Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout [Completed]
Food Effect Study of Febuxostat XR in Healthy Participants [Completed]
Compare the Renal Protective Effects of Febuxostat and Benzbromarone [Recruiting]
Long-Term Safety of Febuxostat in Subjects With Gout. [Completed]
Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule [Completed]
RDEA3170 and Febuxostat Combination Study in Gout Subjects [Active, not recruiting]
Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure [Completed]
Safety and Efficacy of Oral Febuxostat in Subjects With Gout [Completed]
Intensive Urate Lowering Therapy With Febuxostat in Comparison With Allopurinol on Cardiovascular Risk in Patients With Gout [Not yet recruiting]
Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS) [Completed]
An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels. [Completed]
Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients [Completed]
Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies [Completed]
A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout [Completed]
Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy [Active, not recruiting]
the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia [Not yet recruiting]
Phase III Trial of Febuxostat in Korea Gout Patients [Completed]
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat [Completed]
A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients [Completed]
Lesinurad and Febuxostat Combination Extension Study in Gout [Active, not recruiting]
The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients [Recruiting]
Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome [Recruiting]
Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic� in Healthy Volunteers [Completed]
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors [Completed]
Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189 [Completed]
|